An imbalance of gut bacteria in the digestive system contributes to numerous ailments, including heart disease, type 2 diabetes, obesity, Crohn’s disease, Parkinson’s, cognitive issues, immune system suppression and even cancer.
What kind of food never spoils? You get one guess.
With high cholesterol being a major contributor to adverse cardiovascular conditions, MedicalNewsToday.com underscores the importance of paying attention to the type of fats that people eat, as each type can influence cholesterol levels differently.
A Japanese study on boysenberries discovered that the fruit can reduce the amount of bad cholesterol in the body by increasing the latter’s excretion in the small intestine.
When we are eating healthy whole foods with the absence of highly refined carbohydrates, weight gain should not be a problem.
What would motivate a retired married couple to attempt a petition demanding a policy of advising CoQ10 when doctors prescribe cholesterol-lowering statin drugs?
In Japan it is required to prescribe CoQ10 with statin drugs, but not in the U.S.
Peter (Pete) and Terry Mare stumbled on some startling information about statins and CoQ10 as part of their personal experience dealing with the medical establishment and their refusal to remain silent about what they discovered.
by Alliance for Natural Health
Once again the medical establishment gets it completely backward.
NPR recently ran a story that suggests terminally ill patients can safely stop taking cholesterol-reducing statin drugs. The final quote of the article is illuminating: “Most of the studies focus on when to start a medication; there’s been very little focus on when do you stop it.” No surprise there: whether you’re very young or very old, Big Pharma would love you to continue buying statins—for a very long time indeed.
Books by doctors, such as Dr. Ravnskov and Dr. Kendrick, exposing the cholesterol and saturated fat myths have been around for decades.
by Paul Fassa Health Impact News
The cholesterol and calorie hypotheses are both dead — it is time to focus on the real culprit: insulin resistance
By Maryanne Demasi, Robert H Lustig, Aseem Malhotra
The Pharmaceutical Journal
A Penn State Medical School epidemiological study, reported by Science Daily, is urging physicians to not prescribe statin drugs for Parkinson’s disease symptoms. Evidently, due to earlier studies, cholesterol reducing drugs were considered preventative of Parkinson’s disease.
Amazingly, this practice had been going on for some time, thanks to several questionable, and conflicting studies of statin use and Parkinson’s disease. The most recent study was conducted at the Penn State College of Medicine earlier this year (2017.)